Home/Filings/4/0001437749-21-000108
4//SEC Filing

DARGAN CHARLES K 4

Accession 0001437749-21-000108

CIK 0000880242other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:01 PM ET

Size

14.2 KB

Accession

0001437749-21-000108

Insider Transaction Report

Form 4
Period: 2020-12-31
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option to purchase common stock

    2020-12-31+7,5003,588,286 total
    Exercise: $0.12From: 2020-12-31Exp: 2030-12-31Common stock (7,500 underlying)
Footnotes (2)
  • [F1]This Option was granted to Reporting Person to replace options to purchase an aggregate 30,000 shares of Issuer's common stock that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and the Issuer's current stock price, pursuant to a plan adopted by the Issuer's Compensation Committee.
  • [F2]This amount reflects, in addition to the reported option grant, the expiration, during the fourth quarter of 2020, of options to purchase an an aggregate 30,000 shares of common stock.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001112799

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:01 PM ET
Size
14.2 KB